Tevogen Bio Holdings Inc. (TVGN) Ownership
TVGN ownership summary
as of October 18, 2026- Institutions
- 1.6% of shares outstanding
- Insiders
- 72.08% of shares outstanding
- Shares outstanding
- 6.5M
- Float
- 842K shares available to trade
- Short interest
- 2.05% 56K shares short
- Days to cover
- 6.85 short interest down 4.7% vs prior month
- Institutions 1.64%
- Insiders 72.08%
- Other investors 26.28%
TVGN top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard Capital Management, LLC | 0.37% | 24K | $169,510 | −9,272 (−27.9%) | June 30, 2026 |
| 2 | Morgan Stanley - Brokerage Accounts | 0.29% | 19K | $132,980 | +1,475 (+8.5%) | June 30, 2026 |
| 3 | AQR Capital Management LLC | 0.26% | 17K | $121,866 | +17,237 (0.0%) | June 30, 2026 |
| 4 | The Goldman Sachs Group Inc | 0.22% | 14K | $100,132 | +14,163 (0.0%) | June 30, 2026 |
| 5 | Jane Street Group LLC | 0.17% | 11K | $79,007 | +11,175 (0.0%) | June 30, 2026 |
| 6 | FMR Inc | 0.15% | 9,826 | $69,470 | −331 (−3.3%) | June 30, 2026 |
| 7 | Tower Research Capital LLC | 0.02% | 1,494 | $10,563 | +553 (+58.8%) | June 30, 2026 |
| 8 | UBS Group AG | 0.02% | 1,083 | $7,657 | −2,484 (−69.6%) | June 30, 2026 |
| 9 | Vanguard Fiduciary Trust Co | 0.01% | 838 | $5,925 | −530 (−38.7%) | June 30, 2026 |
| 10 | GAMMA Investing LLC | 0.01% | 762 | $5,387 | +622 (+444.3%) | June 30, 2026 |
| 11 | Mercer Global Advisors Inc. | 0.01% | 572 | $4,044 | +572 (0.0%) | June 30, 2026 |
| 12 | SRS Capital Advisors Inc | 0.01% | 401 | $2,835 | +401 (0.0%) | June 30, 2026 |
| 13 | JPMorgan Chase & Co | 0.01% | 393 | $2,779 | −86 (−18.0%) | June 30, 2026 |
| 14 | Integrated Wealth Concepts LLC | <0.01% | 171 | $1,209 | +171 (0.0%) | June 30, 2026 |
| 15 | Royal Bank of Canada | <0.01% | 154 | $1,089 | +33 (+27.3%) | June 30, 2026 |
| 16 | BNP Paribas Arbitrage, SA | <0.01% | 121 | $855 | −161 (−57.1%) | June 30, 2026 |
| 17 | Citigroup Inc | <0.01% | 61 | $431 | +18 (+41.9%) | June 30, 2026 |
| 18 | Hanson Mcclain Inc | <0.01% | 50 | $354 | +50 (0.0%) | June 30, 2026 |
| 19 | Nisa Investment Advisors, L.L.C. | <0.01% | 48 | $339 | +48 (0.0%) | June 30, 2026 |
| 20 | Barclays PLC | <0.01% | 33 | $233 | −216 (−86.7%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 13 holders added 47K shares and 7 cut 13K.
TVGN top mutual fund and ETF holders
8 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 0.23% | 15K | $106,771 | — | August 31, 2026 |
| 2 | Goldman Sachs Absolute Ret Trckr Instl | 0.21% | 14K | $98,634 | +11,331 (+432.5%) | June 30, 2026 |
| 3 | Fidelity Nasdaq Composite Index | 0.06% | 4,081 | $28,853 | — | August 31, 2026 |
| 4 | Vanguard MStar Inst Ttl StkMktIdxInstlPl | 0.05% | 3,536 | $25,000 | — | August 31, 2026 |
| 5 | Fidelity Extended Market Index | 0.02% | 1,463 | $10,343 | — | August 31, 2026 |
| 6 | Fidelity Total Market Index | 0.01% | 357 | $2,524 | — | August 31, 2026 |
| 7 | Fidelity Series Total Market Index | <0.01% | 300 | $2,121 | — | August 31, 2026 |
| 8 | AXAWF Global Dynamic Allocation I CapUSD | 0.00% | 8 | $57 | −2 (−20.0%) | February 28, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
TVGN insider transactions
latest 4| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-13 | Neal Flomenberg | Sell | $6.40 | 501 | $3,206 |
| 2026-03-11 | Neal Flomenberg | Sell | $7.26 | 452 | $3,282 |
| 2026-03-10 | Neal Flomenberg | Sell | $7.75 | 19 | $147 |
| 2025-06-09 | Ryan H Saadi | Sell | $61.50 | 28,764 | $1.8M |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
TVGN shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns TVGN
Institutional investors own 1.6% of Tevogen Bio's shares and insiders 72.08%. The largest holder is Vanguard Capital Management, LLC with 0.37% of the shares (24K), as of June 30, 2026. Among the top 20 institutions, 13 added shares and 7 reduced their stake in the latest filings. Short interest is 2.05% of the float, or 6.85 days of average trading volume. The share count rose 246.3% since 2021.
Related: TVGN analyst forecast, TVGN key metrics. See the TVGN stock overview for the latest quote and news.
TVGN ownership FAQ
Who owns the most Tevogen Bio stock?
The largest shareholders of Tevogen Bio are Vanguard Capital Management, LLC (0.37%), Morgan Stanley - Brokerage Accounts (0.29%), AQR Capital Management LLC (0.26%), The Goldman Sachs Group Inc (0.22%), Jane Street Group LLC (0.17%).
What percentage of Tevogen Bio is owned by institutions?
Institutions hold 1.6% of Tevogen Bio's shares outstanding; insiders hold 72.08%.
Which funds own Tevogen Bio?
The largest fund holders of Tevogen Bio are Vanguard MStar Total Stk Mkt Idx Invest (0.23%), Goldman Sachs Absolute Ret Trckr Instl (0.21%), Fidelity Nasdaq Composite Index (0.06%), Vanguard MStar Inst Ttl StkMktIdxInstlPl (0.05%), Fidelity Extended Market Index (0.02%).
What is Tevogen Bio's short interest?
56K shares of Tevogen Bio were sold short, 2.05% of the float; at the average daily volume it would take 6.85 days to cover.
Are insiders buying or selling Tevogen Bio?
Of the latest 4 reported insider transactions in Tevogen Bio (since June 9, 2025), 0 were purchases and 4 were sales.
How many shares of Tevogen Bio are outstanding?
Tevogen Bio has 6.5M shares outstanding, of which 842K are in the public float.